Immix Biopharma (IMMX) Current Leases (2024 - 2026)

Immix Biopharma (IMMX) reported Current Leases of $125392.0 for Q1 2026, up 84.9% on a YoY basis from $67817.0 in Q1 2025, and down 10.01% sequentially from $139339.0 in Q4 2025.

Immix Biopharma (IMMX) Current Leases (2024 - 2026) Analysis & Trends

Immix Biopharma (IMMX) has 3 years of Current Leases data on file, last reported at $125392.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 84.9% year-over-year to $125392.0; the trailing twelve-month figure through Mar 2026 stood at $125392.0 (up 84.9% YoY), and the FY2025 full-year result was $139339.0, up 113.65% from the prior year.
  • Current Leases eased to $125392.0 in Q1 2026, from $139339.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $141282.0 in Q3 2025 to a low of $34284.0 in Q1 2024.
  • A 3-year average of $83874.9 and a median of $67817.0 in 2025 frame the typical range for Current Leases.
  • Peak annual rise in Current Leases reached 125.28% in 2025, while the deepest fall reached 45.72% in 2025.
  • Tracing IMMX's Current Leases over 3 years: stood at $65219.0 in 2024, then surged by 113.65% to $139339.0 in 2025, then slipped by 10.01% to $125392.0 in 2026.
  • Business Quant data shows IMMX's Current Leases at $125392.0 in Q1 2026, $139339.0 in Q4 2025, and $141282.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 531,233.95
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 20.58 Mn
4 NuCana 279.75 Bn 279.75 Bn - 872,589.03
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.61 Mn
10 Immix Biopharma 487.25 Mn 487.25 Mn - 125,392.00

Historic Data

Download Data
DateValue
Mar 31, 2026 125,392.00
Dec 31, 2025 139,339.00
Sep 30, 2025 141,282.00
Jun 30, 2025 70,467.00
Mar 31, 2025 67,817.00
Dec 31, 2024 65,219.00
Sep 30, 2024 62,715.00
Jun 30, 2024 48,359.00
Mar 31, 2024 34,284.00